144 related articles for article (PubMed ID: 31940499)
1. Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis.
Yokomoto-Umakoshi M; Umakoshi H; Fukumoto T; Matsuda Y; Nagata H; Ogata M; Kawate H; Miyazawa T; Sakamoto R; Ogawa Y;
Bone; 2020 Apr; 133():115221. PubMed ID: 31940499
[TBL] [Abstract][Full Text] [Related]
2. Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma.
Yokomoto-Umakoshi M; Umakoshi H; Sakamoto R; Fukumoto T; Ogata M; Nakano Y; Iwahashi N; Kaneko H; Mizoguchi N; Hattori A; Miyazawa T; Matsuda Y; Kawate H; Ogawa Y;
Bone; 2021 Jan; 142():115607. PubMed ID: 32829039
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service.
Kim JH; Moon H; Noh J; Lee J; Kim SG
Endocrinol Metab (Seoul); 2020 Mar; 35(1):157-164. PubMed ID: 32207276
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of osteoporosis and atherosclerosis in pheochromocytoma: new insights into its long-term management.
Yokomoto-Umakoshi M; Umakoshi H; Ogata M; Fukumoto T; Matsuda Y; Miyazawa T; Sakamoto R; Ogawa Y;
Osteoporos Int; 2020 Nov; 31(11):2151-2160. PubMed ID: 32617610
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.
Taïeb D; Pacak K
Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
7. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
Shetty S; John B; Mohan S; Paul TV
Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
[TBL] [Abstract][Full Text] [Related]
8. Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma.
Lee SH; Park JH; Lee JY; Lee SR; Rhee KS; Chae JK; Kim WH; Sul JY; Oh JK; Kwon HJ; Lee JH; Seong IW
Korean J Intern Med; 2020 Mar; 35(2):351-359. PubMed ID: 30808127
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.
Opotowsky AR; Moko LE; Ginns J; Rosenbaum M; Greutmann M; Aboulhosn J; Hageman A; Kim Y; Deng LX; Grewal J; Zaidi AN; Almansoori G; Oechslin E; Earing M; Landzberg MJ; Singh MN; Wu F; Vaidya A
J Clin Endocrinol Metab; 2015 Apr; 100(4):1325-34. PubMed ID: 25581599
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension.
Constantinescu G; Langton K; Conrad C; Amar L; Assié G; Gimenez-Roqueplo AP; Blanchard A; Larsen CK; Mulatero P; Williams TA; Prejbisz A; Fassnacht M; Bornstein S; Ceccato F; Fliedner S; Dennedy M; Peitzsch M; Sinnott R; Januszewicz A; Beuschlein F; Reincke M; Zennaro MC; Eisenhofer G; Deinum J
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3374-83. PubMed ID: 32609829
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.
Geroula A; Deutschbein T; Langton K; Masjkur J; Pamporaki C; Peitzsch M; Fliedner S; Timmers HJLM; Bornstein SR; Beuschlein F; Stell A; Januszewicz A; Prejbisz A; Fassnacht M; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2019 Oct; 181(4):409-420. PubMed ID: 31370000
[TBL] [Abstract][Full Text] [Related]
12. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas.
Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M
Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783
[TBL] [Abstract][Full Text] [Related]
13. Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas.
Kim KY; Kim JH; Hong AR; Seong MW; Lee KE; Kim SJ; Kim SW; Shin CS; Kim SY
PLoS One; 2016; 11(12):e0168413. PubMed ID: 27992508
[TBL] [Abstract][Full Text] [Related]
14. Acute cardiac complications and subclinical myocardial injuries associated with pheochromocytoma and paraganglioma.
Zhou J; Xuan H; Miao Y; Hu J; Dai Y
BMC Cardiovasc Disord; 2021 Apr; 21(1):203. PubMed ID: 33882857
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas.
Pamporaki C; Hamplova B; Peitzsch M; Prejbisz A; Beuschlein F; Timmers HJLM; Fassnacht M; Klink B; Lodish M; Stratakis CA; Huebner A; Fliedner S; Robledo M; Sinnott RO; Januszewicz A; Pacak K; Eisenhofer G
J Clin Endocrinol Metab; 2017 Apr; 102(4):1122-1132. PubMed ID: 28324046
[TBL] [Abstract][Full Text] [Related]
16. Fractal lacunarity of trabecular bone in vertebral MRI to predict osteoporotic fracture risk in over-fifties women. The LOTO study.
Zaia A; Rossi R; Galeazzi R; Sallei M; Maponi P; Scendoni P
BMC Musculoskelet Disord; 2021 Jan; 22(1):108. PubMed ID: 33485322
[TBL] [Abstract][Full Text] [Related]
17. Clinical differences between small and large pheochromocytomas and paragangliomas.
Zhao L; Li Z; Meng X; Fan H; Zhang Z; Zhang Z; Liu Y; Zhou X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1087506. PubMed ID: 36967797
[TBL] [Abstract][Full Text] [Related]
18. Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas.
Zhao L; Zhang T; Meng X; Zhang Z; Zhou Y; Fan H; Liu Y; Zhou X; Zhu H
Ann Med; 2023 Dec; 55(1):2203945. PubMed ID: 37129505
[TBL] [Abstract][Full Text] [Related]
19. Reduced uptake pattern on
de Jong MC; Pinto D; Parameswaran R
J Surg Oncol; 2023 Oct; 128(5):764-768. PubMed ID: 37403579
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the trabecular bone score (TBS) in routine clinical care of patients with inflammatory rheumatic and non-inflammatory diseases : Correlation with conventional bone mineral density measurement and prevalence of vertebral fractures].
Buehring B; Thomas J; Wittkämper T; Baraliakos X; Braun J
Z Rheumatol; 2020 Dec; 79(10):1067-1074. PubMed ID: 32162022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
